{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:16:45Z","timestamp":1789957005968,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003447","name":"State Scholarships Foundation","doi-asserted-by":"publisher","award":["2019-050-0503-18066"],"award-info":[{"award-number":["2019-050-0503-18066"]}],"id":[{"id":"10.13039\/501100003447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06054-x","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T09:02:59Z","timestamp":1609664579000},"page":"305-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-\/PR- breast cancer cells"],"prefix":"10.1007","volume":"186","author":[{"given":"Elena E.","family":"Tzekaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Geromichalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia N.","family":"Lavrentiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Tsantarliotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Pantazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-3985","authenticated-orcid":false,"given":"Angelos","family":"Papaspyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"6054_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biopha.2018.05.119","volume":"105","author":"S Li","year":"2018","unstructured":"Li S et al (2018) Plasminogen activator inhibitor-1 in cancer research. Biomed Pharmacother 105:83\u201394","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"6054_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13058-014-0428-4","volume":"16","author":"MJ Duffy","year":"2014","unstructured":"Duffy MJ et al (2014) uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res 16(4):428","journal-title":"Breast Cancer Res"},{"issue":"8","key":"6054_CR3","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ejca.2013.01.007","volume":"49","author":"N Harbeck","year":"2013","unstructured":"Harbeck N et al (2013) Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer 49(8):1825\u201335","journal-title":"Eur J Cancer"},{"issue":"3","key":"6054_CR4","first-page":"1153","volume":"34","author":"P Ferroni","year":"2014","unstructured":"Ferroni P et al (2014) Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome. Anticancer Res 34(3):1153\u201361","journal-title":"Anticancer Res"},{"issue":"15","key":"6054_CR5","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","volume":"75","author":"VR Placencio","year":"2015","unstructured":"Placencio VR, DeClerck YA (2015) Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing. Cancer Res 75(15):2969\u201374","journal-title":"Cancer Res"},{"issue":"4","key":"6054_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccr.2008.08.012","volume":"14","author":"K Bajou","year":"2008","unstructured":"Bajou K et al (2008) Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14(4):324\u201334","journal-title":"Cancer Cell"},{"issue":"19","key":"6054_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/jnci\/djs377","volume":"104","author":"H Fang","year":"2012","unstructured":"Fang H, Placencio VR, DeClerck YA (2012) Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function. J Natl Cancer Inst 104(19):1470\u201384","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6054_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427\u201333","journal-title":"Carcinogenesis"},{"issue":"1","key":"6054_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrc2048","volume":"7","author":"VC Jordan","year":"2007","unstructured":"Jordan VC (2007) Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat Rev Cancer 7(1):46\u201353","journal-title":"Nat Rev Cancer"},{"key":"6054_CR10","doi-asserted-by":"crossref","unstructured":"Trabert B, et al (2020) Progesterone and Breast Cancer. Endocr Rev 41(2)","DOI":"10.1210\/endrev\/bnz001"},{"issue":"1","key":"6054_CR11","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1038\/s41598-017-17265-6","volume":"7","author":"S Chen","year":"2017","unstructured":"Chen S et al (2017) The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer. Sci Rep 7(1):16922","journal-title":"Sci Rep"},{"issue":"18","key":"6054_CR12","first-page":"6768","volume":"61","author":"V Syed","year":"2001","unstructured":"Syed V et al (2001) Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61(18):6768\u201376","journal-title":"Cancer Res"},{"key":"6054_CR13","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N, et al (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67-73.","DOI":"10.1038\/nature12113"},{"key":"6054_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fonc.2018.00002","volume":"8","author":"E Di Zazzo","year":"2018","unstructured":"Di Zazzo E et al (2018) Estrogens and their receptors in prostate cancer: therapeutic implications. Front Oncol 8:2","journal-title":"Front Oncol"},{"issue":"7","key":"6054_CR15","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1210\/jc.2012-4000","volume":"98","author":"Y Yu","year":"2013","unstructured":"Yu Y et al (2013) Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control. J Clin Endocrinol Metab 98(7):2887\u201396","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"6054_CR16","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-04-3087","volume":"65","author":"H Ishibashi","year":"2005","unstructured":"Ishibashi H et al (2005) Progesterone receptor in non-small cell lung cancer\u2013a potent prognostic factor and possible target for endocrine therapy. Cancer Res 65(14):6450\u20138","journal-title":"Cancer Res"},{"issue":"1","key":"6054_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/1541-7786.MCR-13-0580","volume":"12","author":"JM Siegfried","year":"2014","unstructured":"Siegfried JM (2014) Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res 12(1):24\u201331","journal-title":"Mol Cancer Res"},{"key":"6054_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fonc.2015.00019","volume":"5","author":"F Caiazza","year":"2015","unstructured":"Caiazza F et al (2015) Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol 5:19","journal-title":"Front Oncol"},{"issue":"1","key":"6054_CR19","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/bcr1639","volume":"9","author":"LK Dunnwald","year":"2007","unstructured":"Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6","journal-title":"Breast Cancer Res"},{"key":"6054_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-018-0116-7","volume":"7","author":"H Hua","year":"2018","unstructured":"Hua H et al (2018) Mechanisms for estrogen receptor expression in human cancer. Exp Hematol Oncol 7:24","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"6054_CR21","first-page":"1617","volume":"7","author":"MC Louie","year":"2017","unstructured":"Louie MC, Sevigny MB (2017) Steroid hormone receptors as prognostic markers in breast cancer. Am J Cancer Res 7(8):1617\u20131636","journal-title":"Am J Cancer Res"},{"issue":"2","key":"6054_CR22","doi-asserted-by":"publisher","first-page":"e56667","DOI":"10.1371\/journal.pone.0056667","volume":"8","author":"CP Yu","year":"2013","unstructured":"Yu CP et al (2013) Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-beta activation. PLoS One 8(2):e56667","journal-title":"PLoS One"},{"issue":"2","key":"6054_CR23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2353\/ajpath.2010.091166","volume":"177","author":"Y Zhai","year":"2010","unstructured":"Zhai Y et al (2010) Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol 177(2):884\u201395","journal-title":"Am J Pathol"},{"issue":"3","key":"6054_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ygyno.2004.11.010","volume":"96","author":"P Lee","year":"2005","unstructured":"Lee P et al (2005) Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol Oncol 96(3):671\u20137","journal-title":"Gynecol Oncol"},{"issue":"2","key":"6054_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","volume":"94","author":"MP Look","year":"2002","unstructured":"Look MP et al (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94(2):116\u201328","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6054_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/01.RES.0000136521.70093.f1","volume":"95","author":"LH Smith","year":"2004","unstructured":"Smith LH et al (2004) Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells. Circ Res 95(3):269\u201375","journal-title":"Circ Res"},{"issue":"1","key":"6054_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001813-200401000-00007","volume":"15","author":"TD Brooks","year":"2004","unstructured":"Brooks TD et al (2004) XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro. Anticancer Drugs 15(1):37\u201344","journal-title":"Anticancer Drugs"},{"issue":"3","key":"6054_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1541-7786.MCR-13-0543","volume":"12","author":"EG Giacoia","year":"2014","unstructured":"Giacoia EG et al (2014) PAI-1 leads to G1-phase cell-cycle progression through cyclin D3\/cdk4\/6 upregulation. Mol Cancer Res 12(3):322\u201334","journal-title":"Mol Cancer Res"},{"issue":"Suppl 1","key":"6054_CR29","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1002\/hed.24124","volume":"38","author":"YC Lee","year":"2016","unstructured":"Lee YC et al (2016) Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers. Head Neck 38(Suppl 1):E895-904","journal-title":"Head Neck"},{"issue":"11","key":"6054_CR30","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1535-7163.MCT-13-0041","volume":"12","author":"T Masuda","year":"2013","unstructured":"Masuda T et al (2013) SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis. Mol Cancer Ther 12(11):2378\u201388","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"6054_CR31","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/jcb.26384","volume":"119","author":"MM Gouda","year":"2018","unstructured":"Gouda MM, Prabhu A, Bhandary YP (2018) Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells. J Cell Biochem 119(2):2222\u20132230","journal-title":"J Cell Biochem"},{"issue":"2","key":"6054_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/or.2016.5292","volume":"37","author":"X Wang","year":"2017","unstructured":"Wang X et al (2017) Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-beta1\/Smad signaling pathway. Oncol Rep 37(2):747\u2013753","journal-title":"Oncol Rep"},{"key":"6054_CR33","doi-asserted-by":"crossref","unstructured":"Papaspyropoulos A et al (2020) Modeling and targeting alzheimer\u2019s disease with organoids. Front Pharmacol 11:396","DOI":"10.3389\/fphar.2020.00396"},{"key":"6054_CR34","doi-asserted-by":"crossref","unstructured":"Tzekaki EE et al (2020) Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer\u2019s disease. Exp Gerontol 144:111178","DOI":"10.1016\/j.exger.2020.111178"},{"key":"6054_CR35","doi-asserted-by":"crossref","unstructured":"Angeloni C et al (2017) Bioactivity of olive oil phenols in neuroprotection. Int J Mol Sci 18(11)","DOI":"10.3390\/ijms18112230"},{"issue":"4","key":"6054_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/carcin\/bgy023","volume":"39","author":"B Corominas-Faja","year":"2018","unstructured":"Corominas-Faja B et al (2018) Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells. Carcinogenesis 39(4):601\u2013613","journal-title":"Carcinogenesis"},{"issue":"12","key":"6054_CR37","doi-asserted-by":"publisher","first-page":"e0189341","DOI":"10.1371\/journal.pone.0189341","volume":"12","author":"M Rossi","year":"2017","unstructured":"Rossi M et al (2017) Protection by extra virgin olive oil against oxidative stress in vitro and in vivo.Chemical and biological studies on the health benefits due to a major component of the Mediterranean diet. PLoS One 12(12):e0189341","journal-title":"PLoS One"},{"issue":"1","key":"6054_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/biof.1318","volume":"43","author":"M Piroddi","year":"2017","unstructured":"Piroddi M et al (2017) Nutrigenomics of extra-virgin olive oil: A review. Biofactors 43(1):17\u201341","journal-title":"Biofactors"},{"issue":"1","key":"6054_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10616-009-9191-2","volume":"59","author":"J Han","year":"2009","unstructured":"Han J et al (2009) Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology 59(1):45\u201353","journal-title":"Cytotechnology"},{"key":"6054_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.fct.2012.12.009","volume":"53","author":"MH Elamin","year":"2013","unstructured":"Elamin MH et al (2013) Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells. Food Chem Toxicol 53:310\u20136","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"6054_CR41","doi-asserted-by":"publisher","first-page":"e97622","DOI":"10.1371\/journal.pone.0097622","volume":"9","author":"MR Akl","year":"2014","unstructured":"Akl MR et al (2014) Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS One 9(5):e97622","journal-title":"PLoS One"},{"key":"6054_CR42","doi-asserted-by":"crossref","unstructured":"Sachs N et al (2019) Long-term expanding human airway organoids for disease modeling. EMBO J 38(4)","DOI":"10.15252\/embj.2018100300"},{"key":"6054_CR43","doi-asserted-by":"crossref","unstructured":"Wiener DJ et al (2018) Establishment and characterization of a canine keratinocyte organoid culture system. Vet Dermatol 29(5):375\u2013e126","DOI":"10.1111\/vde.12541"},{"issue":"W1","key":"6054_CR44","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z et al (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6054_CR45","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z et al (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47(W1):W556\u2013W560","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6054_CR46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41467-017-02786-5","volume":"9","author":"A Papaspyropoulos","year":"2018","unstructured":"Papaspyropoulos A et al (2018) RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73. Nat Commun 9(1):424","journal-title":"Nat Commun"},{"issue":"5","key":"6054_CR47","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00253-012-3913-7","volume":"94","author":"CP Papaneophytou","year":"2012","unstructured":"Papaneophytou CP et al (2012) Flagellin gene (fliC) of Thermus thermophilus HB8: characterization of its product and involvement to flagella assembly and microbial motility. Appl Microbiol Biotechnol 94(5):1265\u201377","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"6054_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JAD-161020","volume":"59","author":"E Andreadou","year":"2017","unstructured":"Andreadou E et al (2017) Rhamnolipids, microbial virulence factors, in Alzheimer\u2019s disease. J Alzheimers Dis 59(1):209\u2013222","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"6054_CR49","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X et al (2017) Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 8(16):3131\u20133141","journal-title":"J Cancer"},{"key":"6054_CR50","doi-asserted-by":"crossref","unstructured":"Uhlen M, et al (2017) A pathology atlas of the human cancer transcriptome. Science 357(6352)","DOI":"10.1126\/science.aan2507"},{"key":"6054_CR51","doi-asserted-by":"publisher","first-page":"35483","DOI":"10.1038\/srep35483","volume":"6","author":"Y Kawarada","year":"2016","unstructured":"Kawarada Y et al (2016) TGF-beta induces p53\/Smads complex formation in the PAI-1 promoter to activate transcription. Sci Rep 6:35483","journal-title":"Sci Rep"},{"issue":"8","key":"6054_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/ncb1448","volume":"8","author":"RM Kortlever","year":"2006","unstructured":"Kortlever RM, Higgins PJ, Bernards R (2006) Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 8(8):877\u201384","journal-title":"Nat Cell Biol"},{"issue":"18","key":"6054_CR53","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1093\/nar\/23.18.3710","volume":"23","author":"C Kunz","year":"1995","unstructured":"Kunz C et al (1995) Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23(18):3710\u20137","journal-title":"Nucleic Acids Res"},{"issue":"28","key":"6054_CR54","doi-asserted-by":"publisher","first-page":"19570","DOI":"10.1074\/jbc.M710268200","volume":"283","author":"S Shetty","year":"2008","unstructured":"Shetty S et al (2008) Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem 283(28):19570\u201380","journal-title":"J Biol Chem"},{"issue":"3","key":"6054_CR55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jcp.1041650324","volume":"165","author":"XC Mu","year":"1995","unstructured":"Mu XC, Higgins PJ (1995) Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts. J Cell Physiol 165(3):647\u201357","journal-title":"J Cell Physiol"},{"issue":"2","key":"6054_CR56","doi-asserted-by":"publisher","first-page":"e56797","DOI":"10.1371\/journal.pone.0056797","volume":"8","author":"S Wang","year":"2013","unstructured":"Wang S et al (2013) PAI-1 4G\/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis. PLoS One 8(2):e56797","journal-title":"PLoS One"},{"key":"6054_CR57","doi-asserted-by":"crossref","unstructured":"Goldsmith CD, et al (2018) The olive biophenols oleuropein and hydroxytyrosol selectively reduce proliferation, influence the cell cycle, and induce apoptosis in pancreatic cancer cells. Int J Mol Sci 19(7)","DOI":"10.3390\/ijms19071937"},{"issue":"4","key":"6054_CR58","doi-asserted-by":"publisher","first-page":"e1006077","DOI":"10.1080\/23723556.2015.1006077","volume":"2","author":"O LeGendre","year":"2015","unstructured":"LeGendre O, Breslin PA, Foster DA (2015) (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization. Mol Cell Oncol 2(4):e1006077","journal-title":"Mol Cell Oncol"},{"key":"6054_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2407-7-80","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA et al (2007) Olive oil\u2019s bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer 7:80","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-06054-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06054-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:03:24Z","timestamp":1674813804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-06054-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6054"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06054-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}